CoChat

Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study

Open access
Soriguer, Federico, Rubio‐Martín, Elehazara, Fernández, David, Valdés, Sergio, García‐Escobar, Eva, Martín‐Núñez, Gracia M., Esteva, Isabel, Almaraz, Mari Cruz, Rojo‐Martínez, Gemma · 2012 · European Journal of Clinical Investigation
Cited by 43

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Eur J Clin Invest 2012; 42 (1): 79–85 Aim To evaluate the association between serum levels of testosterone, sex hormone‐binding globulin (SHBG) and calculated bioavailable testosterone (bioT), and the risk of type 2 diabetes mellitus (T2D) in a prospective cohort from southern Spain (Pizarra study). Research design and methods The study was performed in the Pizarra Cohort Study, a prospective study started in 1995 with a follow‐up of 11 years. Anthropometric and metabolic variables were measured at baseline and at 6 and 11 years of follow‐up. Total testosterone (TT), SHBG and calculated bioT were determined at the 6‐year follow‐up. Results The levels of TT and bioT in men were negatively associated with the risk of obesity, T2D and the metabolic syndrome. In women, the levels of TT and bioT were associated positively with the risk of insulin resistance. The levels of SHBG were associated negatively with the risk of T2D, obesity and insulin resistance in both men and women. For all groups, the association was higher at the 11‐year follow‐up. Conclusions Low levels of testosterone and SHBG increase the risk of T2D in men, and high levels of testosterone increase the risk of insulin resistance in women. The association between TT levels and the risk of T2D is not completely independent of other variables, such as exposure time, adiposity, insulin resistance or SHBG levels. This study also shows that the different responses between men and women are probably because of the protective effect of SHBG, levels of which are higher in women than in men.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.2011.02559.x

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 43

Metadata

Authors
Soriguer, F., Rubio‐Martín, E., Fernández, D., Valdés, S., García‐Escobar, E., Martín‐Núñez, G. M., Esteva, I., Almaraz, M. C., & Rojo‐Martínez, G.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2011-06-16
Volume
42
Issue
1
Pages
79-85
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W1492051437
Cited by
43
References
18
FWCI
2.12
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study. https://app.cochat.ai/papers/10.1111/j.1365-2362.2011.02559.x
The paper
Soriguer, F., Rubio‐Martín, E., Fernández, D., Valdés, S., García‐Escobar, E., Martín‐Núñez, G. M., Esteva, I., Almaraz, M. C., & Rojo‐Martínez, G. (2012). Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2011.02559.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.